CN106070795A - 一种治疗痛风的迷迭香茶 - Google Patents
一种治疗痛风的迷迭香茶 Download PDFInfo
- Publication number
- CN106070795A CN106070795A CN201610424483.7A CN201610424483A CN106070795A CN 106070795 A CN106070795 A CN 106070795A CN 201610424483 A CN201610424483 A CN 201610424483A CN 106070795 A CN106070795 A CN 106070795A
- Authority
- CN
- China
- Prior art keywords
- leaf
- herba
- tea
- folium camelliae
- camelliae assamicae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 244000269722 Thea sinensis Species 0.000 title claims abstract description 55
- 201000005569 Gout Diseases 0.000 title claims abstract description 23
- 244000178231 Rosmarinus officinalis Species 0.000 title claims abstract description 14
- 241000426256 Cyanotis Species 0.000 claims abstract description 30
- 238000002156 mixing Methods 0.000 claims abstract description 12
- 238000004140 cleaning Methods 0.000 claims description 20
- 241000037488 Coccoloba pubescens Species 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 210000003734 kidney Anatomy 0.000 abstract description 12
- 231100000614 poison Toxicity 0.000 abstract description 8
- 239000003440 toxic substance Substances 0.000 abstract description 7
- 239000000843 powder Substances 0.000 abstract description 5
- 235000013616 tea Nutrition 0.000 description 41
- 230000000694 effects Effects 0.000 description 18
- 239000003814 drug Substances 0.000 description 13
- 210000004369 blood Anatomy 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- 238000000855 fermentation Methods 0.000 description 10
- 230000004151 fermentation Effects 0.000 description 10
- 210000000582 semen Anatomy 0.000 description 10
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 9
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 9
- 229940116269 uric acid Drugs 0.000 description 9
- 241000196324 Embryophyta Species 0.000 description 8
- 235000013305 food Nutrition 0.000 description 8
- 239000003205 fragrance Substances 0.000 description 8
- 239000003053 toxin Substances 0.000 description 8
- 231100000765 toxin Toxicity 0.000 description 8
- 208000004880 Polyuria Diseases 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 230000035619 diuresis Effects 0.000 description 6
- 230000008859 change Effects 0.000 description 5
- 239000002934 diuretic Substances 0.000 description 5
- 230000001882 diuretic effect Effects 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 5
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 235000014347 soups Nutrition 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000003064 anti-oxidating effect Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 230000009977 dual effect Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 241000209507 Camellia Species 0.000 description 2
- 235000019224 Camellia sinensis var Qingmao Nutrition 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 241000628997 Flos Species 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241000207923 Lamiaceae Species 0.000 description 2
- 240000005859 Orthosiphon aristatus Species 0.000 description 2
- 241000266298 Phyllagathis Species 0.000 description 2
- 235000006468 Thea sinensis Nutrition 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229960001338 colchicine Drugs 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 238000005336 cracking Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 239000003337 fertilizer Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 238000004898 kneading Methods 0.000 description 2
- 201000008383 nephritis Diseases 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 235000020339 pu-erh tea Nutrition 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 201000003068 rheumatic fever Diseases 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- NKDFYOWSKOHCCO-YPVLXUMRSA-N 20-hydroxyecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(C)(O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 NKDFYOWSKOHCCO-YPVLXUMRSA-N 0.000 description 1
- HXWZQRICWSADMH-SEHXZECUSA-N 20-hydroxyecdysone Natural products CC(C)(C)CC[C@@H](O)[C@@](C)(O)[C@H]1CC[C@@]2(O)C3=CC(=O)[C@@H]4C[C@@H](O)[C@@H](O)C[C@]4(C)[C@H]3CC[C@]12C HXWZQRICWSADMH-SEHXZECUSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 108010087765 Antipain Proteins 0.000 description 1
- 201000002909 Aspergillosis Diseases 0.000 description 1
- 208000036641 Aspergillus infections Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 1
- 206010065553 Bone marrow failure Diseases 0.000 description 1
- 235000014143 Camellia sinensis var assamica Nutrition 0.000 description 1
- 240000008441 Camellia sinensis var. assamica Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012469 Cleome gynandra Nutrition 0.000 description 1
- 241000717675 Clerodendranthus Species 0.000 description 1
- 241000233839 Commelina communis Species 0.000 description 1
- 241000233833 Commelinaceae Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000063328 Cyanotis arachnoidea Species 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- DCEFCUHVANGEOE-UHFFFAOYSA-N Ecdysterone Natural products CC(CC(C)(C)O)C(O)C(C)(O)C1CCC2(O)C3=CC(=O)C4CC(O)C(O)CC4(C)C3CCC12C DCEFCUHVANGEOE-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 244000186654 Fockea angustifolia Species 0.000 description 1
- 235000015210 Fockea angustifolia Nutrition 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000002682 Hyperkalemia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 244000283207 Indigofera tinctoria Species 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010023215 Joint effusion Diseases 0.000 description 1
- 208000000913 Kidney Calculi Diseases 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 241001608027 Lamioideae Species 0.000 description 1
- 244000178870 Lavandula angustifolia Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 244000258329 Ledum groenlandicum Species 0.000 description 1
- 241000209510 Liliopsida Species 0.000 description 1
- 241000218922 Magnoliophyta Species 0.000 description 1
- 206010029148 Nephrolithiasis Diseases 0.000 description 1
- 241001608002 Ocimeae Species 0.000 description 1
- 201000002451 Overnutrition Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241001529742 Rosmarinus Species 0.000 description 1
- 241001122767 Theaceae Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010068887 Tobacco poisoning Diseases 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- OFCNXPDARWKPPY-UHFFFAOYSA-N allopurinol Chemical compound OC1=NC=NC2=C1C=NN2 OFCNXPDARWKPPY-UHFFFAOYSA-N 0.000 description 1
- 229960003459 allopurinol Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000675 anti-caries Effects 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- SDNYTAYICBFYFH-TUFLPTIASA-N antipain Chemical compound NC(N)=NCCC[C@@H](C=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 SDNYTAYICBFYFH-TUFLPTIASA-N 0.000 description 1
- 210000000576 arachnoid Anatomy 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- NKDFYOWSKOHCCO-UHFFFAOYSA-N beta-ecdysone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C)(O)C(O)CCC(C)(O)C)CCC33O)C)C3=CC(=O)C21 NKDFYOWSKOHCCO-UHFFFAOYSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000011443 conventional therapy Methods 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 230000020764 fibrinolysis Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000003760 hair shine Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 201000001819 hydrarthrosis Diseases 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 235000020823 overnutrition Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- -1 polyphenol compound Chemical class 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 229960003081 probenecid Drugs 0.000 description 1
- DBABZHXKTCFAPX-UHFFFAOYSA-N probenecid Chemical compound CCCN(CCC)S(=O)(=O)C1=CC=C(C(O)=O)C=C1 DBABZHXKTCFAPX-UHFFFAOYSA-N 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 201000007094 prostatitis Diseases 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000004144 purine metabolism Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000004223 radioprotective effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000008327 renal blood flow Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 239000001331 rosmarinus officinalis leaf Substances 0.000 description 1
- 235000012045 salad Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229960003329 sulfinpyrazone Drugs 0.000 description 1
- MBGGBVCUIVRRBF-UHFFFAOYSA-N sulfinpyrazone Chemical compound O=C1N(C=2C=CC=CC=2)N(C=2C=CC=CC=2)C(=O)C1CCS(=O)C1=CC=CC=C1 MBGGBVCUIVRRBF-UHFFFAOYSA-N 0.000 description 1
- JLKIGFTWXXRPMT-UHFFFAOYSA-N sulphamethoxazole Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 JLKIGFTWXXRPMT-UHFFFAOYSA-N 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 210000001171 synovial bursa Anatomy 0.000 description 1
- 210000001258 synovial membrane Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 230000003424 uricosuric effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
- A23F3/14—Tea preparations, e.g. using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种治疗痛风的迷迭香茶，按普洱茶[普洱生茶(以古树茶为最佳)或普洱熟茶(宫廷普洱茶)]占总重量份的65％～70％，迷迭香叶占总重量份的10％～13％，粗粉过的珍珠露水草根占总重量份的10％～11％，粗粉过的猫须草茎叶占总重量份的10％～11％比例均匀混合，将其压制成重量为5～6克的迷你小沱茶，获得治疗痛风、清热解毒、养肾的迷迭香茶。
Description
技术领域
本发明涉及一种清热解毒、治疗痛风、养肾的保健型迷迭香茶。
背景技术
随着人民生活水平的提高和饮食结构的改变，人体由于嘌呤生物合成代谢增加，而体内吸收缓慢，而导致尿酸产生过多或因尿酸分解、排泄不良而致血中尿酸升高，甚至尿酸盐结晶沉积在关节滑膜、滑囊、软骨及其他组织中引起的反复发作性炎性疾病。目前，痛风已经成为一种较普扁的疾病。痛风的常规治疗，主要是使用秋水仙碱或非类固醇抗炎药(NSAID)，但作为化学药品，秋水仙碱副作用较大，出现副作用会引起腹泻并造成严重的电解质紊乱等严重后果；也会引起严重的骨髓抑制，甚至死亡。非类固醇抗炎药(NSAID)会引起许多并发症，包括胃肠道不适，高钾血症(出现于那些依赖前列腺素E2维持肾血流量的病人)和体液潴留。用NSAID有特别危险的病人包括老年病人，脱水者，尤其有肾脏疾病史的病人。当然，药物治疗也还有抽吸关节积液，随后注入皮质类固醇酯；口服丙磺舒(500mg片剂)或苯磺唑酮(100mg片剂)促进尿酸排泄疗法；用别嘌呤醇200～600mg/d(分次用)抑制尿酸合成，同样也能控制血清尿酸盐浓度等等，但副作用均不少。
传统的中医中药，也有治疗痛风的方剂，这些方剂没有本发明中的组合方剂，而且传统的方剂需要将方剂中的中药材煮熬后服用，比较麻烦，在现代快节奏的环境条件下，不太受欢迎。
本发明不使用化学药物，就极大地减少了药物给痛风病人带来的副作用；本发明不需要像中药方剂进行煮熬；本发明选择食品及食药兼用的植物，制成迷你普洱小沱茶，通过喝茶水的方式达到治疗痛风的效果。
本发明选择的食品普洱茶及药食两用植物为：
迷迭香为种子植物门Spermatophyta被子植物亚门Angiospermae双子叶植物Dicotyledons菊亚纲Asteridae唇形目Lamiales唇形科Labiatae野芝麻亚科Lamioideae迷迭香族Rosmarineae迷迭香属Rosmarinus多年生常绿亚灌木植物迷迭香Herba RosmariniOfficinalis的叶和花。英文名：Rosemary。系多年生长绿亚灌木，株高40-80厘米，多分枝，叶片长披针形或线形，花淡紫色、黄色或粉白色。
迷迭香也称“玫瑰玛丽”。原产于欧洲南部、北非及地中海沿岸一带,是欧洲古老而传统的香料和食品添加剂作物。迷迭香嫩叶常用于沙拉配料、食品调味及鱼肉类食品烹饪中，有增加风味、去除腥膻味的效果。
迷迭香叶、花香气浓烈，有杀灭病菌、净化空气、提神醒脑、增强记忆力、促进血液循环的功效，对神经、消化及呼吸系统疾病均有治疗作用。
迷迭香性温、平，味辛，无毒。主要功能为驱邪气、安神，芳香健胃，疏通经络、抗炎、镇痛、解毒。
迷迭香中所含的抗氧化物质能够促进人体免疫功能，清除人体自由基；能促进人体纤维蛋白溶解，刺激并加快人体的脂肪代谢，促进脂类化合物从粪便中排出；能抑制血小板聚集和血栓形成，明显地抑制血浆和肝脏中胆固醇含量上升，降血脂、降血压；能够抗炎、镇痛、解毒。
宫廷普洱茶，为种子植物门Spermatophyta被子植物亚门Angiospermae双子叶植物Dicotyledons五桠果亚纲Dilleniidae山茶目Theales山茶科Theaceae山茶亚科Theoideae山茶族Trib.Theeae DC.山茶属Camellia L.植物茶Camellia sinensis(L.)O.Kuntze的变种云南大叶种茶Camellia sinensis var.assamica(Mast.)Kitamura经过晒青、后发酵(快速后发酵或缓慢后发酵)加工形成的散茶。
宫廷普洱茶是世界三大饮料之首的茶中的一个主要品种，宫廷普洱茶由于他的茶多酚特别是儿茶素含量高，而且还由于在其后发酵中一系列酶促氧化和微生物活动复杂的变化过程产生曲菌等，使得饮普洱茶后脑血管的生理状态和脑血流动力学状态都发生了变化。饮用普洱茶具有降脂、改善胰岛素抗拒及预防心血管疾病的效果；具有明显的抗氧化活性，清除自由基，降低LDI不饱和脂肪酸的数量及增加LDL生育酚的含量，以降低LDL的氧化敏感度等，因此，可预防动脉粥状硬化及心血管疾病的发生。同时普洱茶还具有多种丰富的抗痛微量成分，如Q-胡萝卜素，维生素B1,B2,C,E等。
中医认为，普洱茶同时具有清热、消暑、解毒、消食、去腻、利水、通便、祛痰、祛风解表、止咳生津、益气、延年益寿等功效。现代医学对普洱茶功效的研究得出的结论认为，普洱茶有暖胃、减肥、降脂、防止动脉硬化、防止冠心病、降血压、抗衰老、抗癌、降血糖、抑菌消炎、减轻烟毒、减轻重金属毒、抗辐射、防龋齿、明目、助消化、抗毒、预防便秘、解酒等20多项功效，而其中暖胃、减肥、降脂、防止动脉硬化、防止冠心病、降血压、抗衰老、抗癌、降血糖的功效尤为突出。
珍珠露水草为种子植物门Spermatophyta被子植物亚门Angiospermae单子叶植物Monocotyledons鸭跖草分支Commelina communis鸭跖草目Commelinales鸭跖草科Commelinaceae鸭跖草亚科Commelinoideae蓝耳草属Cyanotis植物露水草Cyanotisarachnoidea C.B.Clarke in DC.根。英文名：root of Arachnoid Cyanotis。
珍珠露水草为云南省特有的彝族药食两用植物药，彝族药名：卓达荷奇诺、欺通若。作为食疗植物，云南本土人群经常用珍珠露水草的根炖肉、炖鸡等食补。
珍珠露水草历代本草及医籍未见记载，是彝族常用草药，首载于《云南中草药》和《昆明民间常用草药》，继后《全国中草药汇编》及《中药大辞典》均收载。珍珠露水草味甘、性平、微苦。主要功能为祛风活络，利湿消肿，退虚热。常用于风湿性关节炎，四肢麻木，腰腿痛，肾炎水肿，虚热不退。
珍珠露水草中含有的蜕皮甾酮是一种天然的超强抗氧化物，它能够抑制高血糖、降低血糖和胆固醇；它能够显著的通过增加氨基酸装配成蛋白链，从而刺激肌肉细胞细胞质中蛋白质合成的能力，可以通过改善肝功能从而使机体能迅速地适应环境和压力变化；它能促进肌肤细胞的再生、防衰老、抗癌、抗氧化等作用，并能提高其免疫力。
猫须草为种子植物门Spermatophyta被子植物亚门Angiospermae双子叶植物Dicotyledons菊亚纲Asteridae唇形目Lamiales唇形科Labiatae罗勒亚科Ocimoideae罗勒族Ocimeae肾茶属Clerodendranthus植物猫须草Clerodendranthus spicatus(Thunb.)C.Y.Wu的地上部分。英文名：Herb of Spicate Clerodendranthus。
猫须草是云南傣族传统凉茶之一。西双版纳傣语称：牙努秒。又名：肾茶，猫须公。
猫须草味甘、性凉、微苦。主要功能为清热祛湿，通淋排石，利尿。用于治疗急性肾炎、膀胱炎、肾结石、尿路结石、胆结石、前列腺炎、前列腺增生、血尿酸高、痛风、肾虚腰酸、风湿性关节炎。
肾脏是人体主要排毒器官，藉由排出尿液，可将体内新陈代谢产生的尿酸、废物和酸性物质等毒素排出体外。猫须草是一种效果经获证实的利尿剂，具有净化肾脏、加强排除毒素和滞留水分的绝佳功能，而且与化学药物利尿剂不同，猫须草没有如化学合成利尿剂常见的毒副作用。猫须草在排出水分的同时，不会造成体内电解质不平衡，它含有大量的钾，能补充在排毒或排除水分时所流失的电解质。猫须草天然及温和的作用，不会增加肾脏负担，保护肾脏；猫须草富含多酚类化合物，包括类黄酮和皂苷，能发挥强效抗氧化作用，保护人体细胞免于因自由基侵害而造成大量DNA和细胞受损；猫须草的消炎作用可助减轻肿痛不适，进而舒缓关节和肌肉酸痛症状。同时它也帮助将聚集在关节和肌肉的尿酸和毒素排出体外，预防这些年累积的尿酸和毒素刺激患处，造成酸痛和发炎；猫须草还具有能通过排尿去除过剩的钠(盐)，从而预防和消除体内结石，对于老痛风患者可以消除因长期痛风导致的关节部位因尿酸及毒素长年积累的类似结石。
发明内容
针对上述问题，本发明的目的是提供一种治疗痛风的迷迭香茶，其工艺制备方法包括以下步骤：
步骤一、选取普洱茶；
步骤二、选取迷迭香叶和花；
步骤三、选取珍珠露水草的根；
步骤四、选取猫须草的茎叶；
步骤五、按照普洱茶占总重量份的65％～70％，迷迭香叶和花占总重量份的10％～13％，粗碎过的珍珠露水草根占总重量份的10％～11％，粗碎过的猫须草茎叶占总重量份的10％～11％比例均匀混合；
步骤六、普洱茶、迷迭香叶、珍珠露水草根、猫须草茎叶按步骤五所述比例均匀混合后，将其压制成重量为5～6克的迷迭香普洱小沱茶。
步骤一所述的普洱茶为大叶种古树普洱生茶或大叶种晒青茶为原料，采用特定工艺加工形成的散茶。
古树普洱生茶，经杀青、揉捻、日光干燥等工艺制成的散茶。其品质特征为：外形色泽墨绿、香气清纯持久、滋味浓厚回甘、汤色绿黄清亮，叶底肥厚黄绿。
普洱熟茶(宫廷普洱茶)，经后发酵(快速后发酵或缓慢后发酵)加工形成的散茶。其品质特征为：外形色泽红褐，内质汤色红浓明亮，香气独特陈香，滋味醇厚回甘，叶底红褐。
步骤二所述的迷迭香叶和花，必须是选自经过清洗阴干的迷迭香叶和花，不带枝。
步骤三所述的珍珠露水草根，必须是选自经过清洗阴干并粗碎为芝麻大的珍珠露水草的根。
步骤四所述的猫须草茎叶，必须是选自经过清洗阴干并粗碎为芝麻大的猫须草的茎叶。
步骤五所述的配伍比例，必须是按宫廷普洱茶占总重量份的65％～70％；迷迭香叶和花占总重量份的10％～13％；粗碎过的珍珠露水草根占总重量份的10％～11％；粗碎过的猫须草茎叶占总重量份的10％～11％的比例均匀混合。
步骤六所述迷你型迷迭香普洱小沱茶，必须是将前述的普洱茶(古树普洱茶或宫廷普洱茶)、迷迭香叶、珍珠露水草根、猫须草茎叶按步骤五的比例均匀混合后，将其压制成重量为5～6克的迷你型功能性迷迭香普洱小沱茶。
本发明的有益效果是：本发明的迷迭香茶不但具有迷迭香的香气，同时还具有厚重的普洱茶(古树普洱茶或宫廷普洱茶)的味道，口感好。消费者在喝茶过程中清热解毒、养肾利尿、防治痛风。
具体实施方式
一种治疗痛风的迷迭香茶，其工艺制备方法包括以下步骤：步骤一、选取普洱茶[普洱生茶(以古树茶为最佳)或普洱熟茶(宫廷普洱茶)]；步骤二、选取迷迭香叶和花；步骤三、选取珍珠露水草的根；步骤四、选取猫须草的茎叶；步骤五、按照普洱茶占总重量份的65％～70％，迷迭香叶和花占总重量份的10％～13％，粗碎过的珍珠露水草根占总重量份的10％～11％，粗碎过的猫须草茎叶占总重量份的10％～11％比例均匀混合；步骤六、普洱茶、迷迭香叶、珍珠露水草根、猫须草茎叶按步骤五所述比例均匀混合后，将其压制成重量为5～6克的迷迭香普洱小沱茶。
步骤一所述的普洱茶，必须是按云南省地方标准DB53/103-2006，DB53/T171-173-2006的要求，以符合普洱茶产地环境条件的云南大叶种古树普洱生茶或云南大叶种晒青茶为原料，采用特定工艺加工形成的散茶。
古树普洱生茶，经杀青、揉捻、日光干燥等工艺制成的散茶。其品质特征为：外形色泽墨绿、香气清纯持久、滋味浓厚回甘、汤色绿黄清亮，叶底肥厚黄绿。
普洱熟茶(宫廷普洱茶)，经后发酵(快速后发酵或缓慢后发酵)加工形成的散茶。其品质特征为：外形色泽红褐，内质汤色红浓明亮，香气独特陈香，滋味醇厚回甘，叶底红褐。
步骤二所述的迷迭香叶和花，必须是选自经过清洗阴干的迷迭香叶和花，不带枝。
步骤三所述的珍珠露水草根，必须是选自经过清洗阴干并粗碎为芝麻大的珍珠露水草的根。
步骤四所述的猫须草茎叶，必须是选自经过清洗阴干并粗碎为芝麻大的猫须草的茎叶。
步骤五所述的配伍比例，必须是按宫廷普洱茶占总重量份的65％～70％；迷迭香叶和花占总重量份的10％～13％；粗碎过的珍珠露水草根占总重量份的10％～11％；粗碎过的猫须草茎叶占总重量份的10％～11％的比例均匀混合。
步骤六所述迷你型迷迭香普洱小沱茶，必须是将前述的普洱茶(古树普洱茶或宫廷普洱茶)、迷迭香叶、珍珠露水草根、猫须草茎叶按步骤五的比例均匀混合后，将其压制成重量为5～6克的迷你型功能性迷迭香普洱小沱茶。
实施例1：
取达到宫廷普洱茶生产标准的宫廷普洱茶70kg，取经过清洗阴干的迷迭香花和叶10kg，取经过清洗阴干并粗碎为芝麻大的珍珠露水草的根10kg，取经过清洗阴干并粗粉为芝麻大的猫须草的茎叶10kg，将其均匀混合，采用迷你小沱茶压制设备将其压制成重量为5～6克的迷你型功能性迷迭香普洱小沱茶。
实施例2：
取达到宫廷普洱茶生产标准的宫廷普洱茶65kg，取经过清洗阴干的迷迭香花和叶13kg，取经过清洗阴干并粗碎为芝麻大的珍珠露水草的根11kg，取经过清洗阴干并粗粉为芝麻大的猫须草的茎叶11kg，将其均匀混合，采用迷你小沱茶压制设备将其压制成重量为5～6克的迷你型功能性迷迭香普洱小沱茶。
实施例3：
取经过清洗阴干的珍珠露水草根12kg，取经过清洗阴干的猫须草12kg，将其均匀混合，进入粗粉机粉碎为芝麻大小的颗粒，经过称量(即去除粉碎的损耗)再按比例加入65kg左右的宫廷普洱茶，按比例加入12kg左右的经过清洗阴干的迷迭香花和叶，再一次均匀混合，采用迷你小沱茶压制设备将其压制成重量为5～6克的迷你型功能性迷迭香普洱小沱茶。
实施例4：
取经过清洗阴干的珍珠露水草根12kg，取经过清洗阴干的猫须草12kg，取经过清洗阴干的迷迭香花和叶12kg，将其均匀混合，进入粗粉机粉碎为芝麻大小的颗粒，经过称量(即去除粉碎的损耗)再按比例加入65kg左右的宫廷普洱茶，再一次均匀混合，采用迷你小沱茶压制设备将其压制成重量为5～6克的迷你型功能性迷迭香普洱小沱茶。
本发明针对目前痛风成为营养过剩、亚健康人群的一种常见病，用西药治疗痛风，对治疗人群的副作用明显，而且往往治标不治本。本发明将中国人习惯饮用的，具有减肥、降脂、解毒、利水、祛风、解表等功效的普洱茶，组配上能够疏通经络、抗炎、镇痛、解毒的香草植物迷迭香叶，组配上能够祛风活络，利湿消肿的云南特有的彝族药食两用植物珍珠露水草根及能够净化肾脏、排清毒素、清热利湿、通淋排石、抗菌消炎的猫须草，制成消费者均喜欢喝的迷迭香茶饮，不但具有迷迭香的香气，同时还具有厚重的宫廷普洱茶的味道，口感好。消费者在喝茶过程中清热解毒、养肾利尿、防治痛风。
以上仅为本发明的一些实施方式，对于本领域普通技术人员来说，在不脱离本发明创造构思的前提下，还可进行若干变形和改进，这些都属于本发明的保护范围。
Claims (5)
1.一种治疗痛风的迷迭香茶，其特征在于：其工艺制备方法，包括以下步骤：
步骤一、选取普洱茶；
步骤二、选取迷迭香叶和花；
步骤三、选取珍珠露水草的根；
步骤四、选取猫须草的茎叶；
步骤五、按照普洱茶占总重量份的65％～70％，迷迭香叶和花占总重量份的10％～13％，粗碎过的珍珠露水草根占总重量份的10％～11％，粗碎过的猫须草茎叶占总重量份的10％～11％比例均匀混合；
步骤六、普洱茶、迷迭香叶、珍珠露水草根、猫须草茎叶按步骤五所述比例均匀混合后，将其压制成重量为5～6克的迷迭香普洱小沱茶。
2.如权利要求1所述的一种治疗痛风的迷迭香茶，其特征在于：步骤一中，普洱茶选取大叶种的普洱生茶或普洱熟茶。
3.如权利要求1所述的一种治疗痛风的迷迭香茶，其特征在于：步骤二中，迷迭香叶和花选取经过清洗阴干的迷迭香叶和花。
4.如权利要求1所述的一种治疗痛风的迷迭香茶，其特征在于：步骤三中，珍珠露水草根选取经过清洗阴干并粗碎为长度为0.5-4mm的珍珠露水草的根。
5.如权利要求1所述的一种治疗痛风的迷迭香茶，其特征在于：步骤四中，猫须草的茎叶选自经过清洗阴干并粗碎为长度为0.5-4mm的猫须草的茎叶。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610424483.7A CN106070795A (zh) | 2016-06-15 | 2016-06-15 | 一种治疗痛风的迷迭香茶 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610424483.7A CN106070795A (zh) | 2016-06-15 | 2016-06-15 | 一种治疗痛风的迷迭香茶 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106070795A true CN106070795A (zh) | 2016-11-09 |
Family
ID=57846049
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610424483.7A Pending CN106070795A (zh) | 2016-06-15 | 2016-06-15 | 一种治疗痛风的迷迭香茶 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106070795A (zh) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1814202A (zh) * | 2005-11-24 | 2006-08-09 | 蓝子花 | 一种红毛七祛湿镇痛药酒 |
| CN101263852A (zh) * | 2008-04-28 | 2008-09-17 | 吴锦华 | 肾茶保健茶 |
-
2016
- 2016-06-15 CN CN201610424483.7A patent/CN106070795A/zh active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1814202A (zh) * | 2005-11-24 | 2006-08-09 | 蓝子花 | 一种红毛七祛湿镇痛药酒 |
| CN101263852A (zh) * | 2008-04-28 | 2008-09-17 | 吴锦华 | 肾茶保健茶 |
Non-Patent Citations (1)
| Title |
|---|
| 谢文英: "《养生茶饮新知全书》", 31 May 2013, 陕西科学技术出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101176590B1 (ko) | 숙취 해소용 한약 조성물 및 이를 함유하는 음료 | |
| KR101090284B1 (ko) | 홍삼과 녹용 추출물을 포함하는 드링크제 및 그의 제조방법 | |
| CN104186771A (zh) | 一种保健绿茶及其加工配制方法 | |
| CN105112265A (zh) | 一种保健无花果酒及其制作方法 | |
| CN103891962B (zh) | 一种美容瘦身的保健茶及其制备方法 | |
| CN110564570A (zh) | 一种沉香风味白酒配方及方法 | |
| CN103749824A (zh) | 一种绞股蓝降糖降压保健茶及其制备方法 | |
| CN105567501A (zh) | 一种威灵仙风味荸荠果酒的酿制方法 | |
| KR100528147B1 (ko) | 어성초와 삼백초를 주성분으로 한 추출물과 이를 응용한 환 및 발효주 제조방법 | |
| CN104147147B (zh) | 一种用于治疗皮肤病的中药组合物及制备方法 | |
| CN104095269B (zh) | 一种纯天然接骨木籽果饮的制备 | |
| KR101402852B1 (ko) | 발효도라지환 및 이의 제조방법 | |
| CN104544084A (zh) | 一种用于糖尿病患者的保健食品 | |
| CN103960415A (zh) | 一种减肥保健凉茶及其制备方法 | |
| CN104013844A (zh) | 一种促进生发中药制剂的配方及制备方法 | |
| CN105455125A (zh) | 一种提高免疫力的龙眼肉口服液及其制备方法 | |
| CN106070795A (zh) | 一种治疗痛风的迷迭香茶 | |
| CN105617268A (zh) | 一种治疗鳞屑角化型脚气的药物 | |
| CN112294708A (zh) | 一种弱酸性洗发护发活性洗剂 | |
| CN106479823A (zh) | 一种水曲柳风味牛蒡根枫藤果保健果酒 | |
| CN105394279A (zh) | 一种添加中药的降脂减肥茶及其制备方法 | |
| KR20200061285A (ko) | 가랑갈 추출물을 포함하는 혈액순환 및 혈관질환 예방용 식품 조성물 | |
| CN106434176A (zh) | 具有降三高功能的保健酒及其生产方法 | |
| CN108013170A (zh) | 双仁润金茶 | |
| CN107510771B (zh) | 一种治疗鸭嗜水气单胞菌病的中药组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161109 |